Qualigen Therapeutics, Inc. — Proxy Solicitation & Information Statement 2017

Apr 21, 2017

DEFA14A 1 defa14a.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN

PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant To Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant [X]

Filed by a Party other than the Registrant [ ]

Check the appropriate box:

| [ ] | Preliminary Proxy Statement | | --- | --- | | [ ] | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | | [ ] | Definitive Proxy Statement | | [X] | Definitive Additional Materials | | [ ] | Soliciting Material Pursuant to § 240.14a-12 |

Ritter Pharmaceuticals, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the Appropriate Box):

[X]	No fee required.
[ ]	Fee computed
on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
	(1)	Title
of each class of securities to which transaction applies:
	(2)	Aggregate
number of securities to which transaction applies:
	(3)	Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined):
	(4)	Proposed
maximum aggregate value of transaction:
	(5)	Total
fee paid:
[ ]	Fee paid
previously with preliminary materials.
[ ]	Check box
if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date
of its filing.
	(1)	Amount
Previously Paid:
	(2)	Form,
Schedule or Registration Statement No.:
	(3)	Filing
Party:
	(4)	Date
Filed:

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Field: Page; Sequence: 2

Field: /Page

Field: Page; Sequence: 3

Field: /Page

Field: Page; Sequence: 4

Field: /Page

Field: Page; Sequence: 5

Field: /Page